The primary objective of this study is to evaluate the long-term safety of desvenlafaxine succinate sustained release tablets during 10-month open-label treatment of Japanese subjects with major depre
BackgroundPolymyxins are the last line of defense against carbapenem-resistant Gram-negative bacilli infections. However, the efficacy of polymyxins against the independent risk factor of bacterial sp
Mild adverse events were defined as complications resolving spontaneously within one hour and included rash (14 cases, 17.3%), pruritus (5 cases, 6.2%), nausea (9 cases, 11.1%) and headache (3 cases,